Truist bullish on diabetes companies citing potential market growth
Source: SeekingAlpha
2025-06-16 11:24:21 ET
More on DexCom, Insulet, Tandem
- Tandem Diabetes Care: A Barbell Bet On A High-Stakes Turnaround
- Insulet Corporation: Shares Remain Astronomically Expensive
- DexCom Q1 Earnings: Organic Revenue Growth Versus Cost Pressure
- Tandem, Abbott in deal to combine insulin delivery with glucose-ketone sensor
- Tandem to pay Roche $36M in patent dispute settlement
Read the full article on Seeking Alpha
For further details see:
Truist bullish on diabetes companies citing potential market growth
Tandem Diabetes Care Inc.
NASDAQ: TNDM
TNDM Trading
1.25% G/L:
$21.91 Last:
132,356 Volume:
$21.51 Open:
TNDM Latest News
February 25, 2026 12:30:00 am
Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032
February 23, 2026 06:33:18 pm
Exposure Surge, Immunotherapy Expansion, and a $1.1B Healthcare Takeout
February 23, 2026 04:05:00 pm
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
TNDM Stock Data
$1,337,401,531
66,514,114
0.48%
99
N/A
Medical Equipment & Supplies
Healthcare
US
San Diego
